SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (552)1/20/1998 5:03:00 PM
From: Vector1  Respond to of 1686
 
Rick,
I am looking forward to the BioPlatform launch and the CD40L discussion.
Frankly I think the past weeks price movement on BGEN is primarily the result of reaccelleration of Avonex sales in both the US and Europe and the possibility that the Avonex market will be expanded for use in earlier stage cases. If the pipeline starts to get real recognition we are in for a great year. I hope so, I loaded up at 35 a few weeks ago.
V1



To: scaram(o)uche who wrote (552)1/20/1998 7:41:00 PM
From: mike head  Read Replies (3) | Respond to of 1686
 
Rick and Vector1. A couple of questions. 1)V1- I thought the 'I' in ITP stood for 'ideopathic', or is that now obsolete. Things change fast <g>. And Rick, how do I find out about Bio Platform? Pax et Bonum, mch


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News